Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Beta-Hydroxybutyrate May Outperform NAD+ as a Longevity MetaboliteNutrition & Diet

Beta-Hydroxybutyrate May Outperform NAD+ as a Longevity Metabolite

This video examines beta-hydroxybutyrate (bHB), a ketone body produced during fasting or ketogenic eating, arguing it may surpass NAD+ as a longevity-relevant metabolic compound. Thomas DeLauer and Dr. Jacob Torres cover how bHB acts not just as fuel but as an epigenetic signal, influencing gene expression through a process called acylation. They discuss its anti-inflammatory properties, its role in gut barrier integrity, kidney health, and heart function. The conversation also explores practical protocols for people over 40, comparing intermittent ketosis versus exogenous ketone supplementation. Niacin's relationship with bHB and fat mobilization is also unpacked, along with why blood ketone meters may underreport tissue-level ketone activity.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.